Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________ FORM 10-K _____________________________________ (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36522 ________________________________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 _____________________________________ FORM 10-Q _____________________________________ (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36522 Investar Holding Corporation (Exact name of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 _____________________________________ FORM 10-Q _____________________________________ (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36522 Investar Holding Corporation (Exact name of regis ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 _____________________________________ FORM 10-Q _____________________________________ (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36522 Investar Holding Corporation (Exact name of regi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________ FORM 10-K _____________________________________ (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36522 Investar Holding Corporation (Ex ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 _____________________________________ FORM 10-Q _____________________________________ (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36522 Investar Holding Corporation (Exact name of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 _____________________________________ FORM 10-Q _____________________________________ (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36522 Investar Holding Corporation (Exact name of regis ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 _____________________________________ FORM 10-Q _____________________________________ (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36522 Investar Holding Corporation (Exact name of regi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Washington, D.C. 20549 _____________________________________ Commission File Number: 001-36522 ____________________________________________________ FORM 10-K _____________________________________ Investar Holding Corporation (Mark One) (E ...

Part I. Financial Information [Item 1. Financial Statements](index=4&type=section&id=Item%201.%20Financial%20Statements) This section presents Investar Holding Corporation's unaudited consolidated financial statements, including balance sheets, income statements, cash flows, and detailed notes, for the period ended September 30, 2020 [Consolidated Balance Sheets](index=4&type=section&id=Consolidated%20Balance%20Sheets) Total assets increased to $2.32 billion, driven by loan growth, while liabilities rose to $2.09 billion, and stockholders' equity slightly decreased Consolidated Balance Sheet Highlights (in thousands) | Account | Sep 30, 2020 (Unaudited) | Dec 31, 2019 | | :--- | :--- | :--- | | **Total Assets** | **$2,323,245** | **$2,148,916** | | Loans, net | $1,810,636 | $1,681,275 | | Total Deposits | $1,834,449 | $1,707,706 | | **Total Liabilities** | **$2,085,978** | **$1,906,940** | | **Total Stockholders' Equity** | **$237,267** | **$241,976** | [Consolidated Statements of Income](index=5&type=section&id=Consolidated%20Statements%20of%20Income) Net income for the nine months ended September 30, 2020, decreased to $9.3 million, primarily due to a substantial increase in the provision for loan losses Income Statement Summary (in thousands, except per share data) | Metric | Nine Months Ended Sep 30, 2020 | Nine Months Ended Sep 30, 2019 | | :--- | :--- | :--- | | Net Interest Income | $54,380 | $47,853 | | Provision for loan losses | $8,760 | $1,172 | | Total Noninterest Income | $8,421 | $4,641 | | Total Noninterest Expense | $42,438 | $34,539 | | **Net Income** | **$9,349** | **$13,508** | | Diluted EPS | $0.85 | $1.34 | [Consolidated Statements of Cash Flows](index=9&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) Operating activities provided $11.3 million, investing activities used $132.4 million, and financing activities provided $127.0 million, resulting in a $5.9 million net cash increase Cash Flow Summary (in thousands) | Activity | Nine Months Ended Sep 30, 2020 | Nine Months Ended Sep 30, 2019 | | :--- | :--- | :--- | | Net cash provided by operating activities | $11,288 | $13,737 | | Net cash used in investing activities | $(132,390) | $(78,865) | | Net cash provided by financing activities | $126,960 | $76,989 | | **Net change in cash and cash equivalents** | **$5,858** | **$11,861** | [Notes to the Consolidated Financial Statements](index=11&type=section&id=Notes%20to%20the%20Consolidated%20Financial%20Statements) This section details accounting policies, including COVID-19 impacts, business combinations, loan portfolio, allowance for loan losses, and fair value measurements - The company adopted accounting for loan modifications pursuant to the **CARES Act**, allowing it to suspend GAAP for modifications related to the pandemic that would otherwise be categorized as troubled debt restructurings (**TDRs**)[58](index=58&type=chunk) - As of September 30, 2020, the balance of loans participating in the 90-day deferral program due to COVID-19 was **$56.5 million**, or **3.1%** of the total loan portfolio, and these loans are not accounted for as TDRs, past due, or nonaccrual[61](index=61&type=chunk) - The company is preparing for the adoption of **ASU 2016-13 (CECL model)** effective **January 1, 2023**, which is expected to result in an increase in the allowance for loan losses[62](index=62&type=chunk)[63](index=63&type=chunk)[64](index=64&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=46&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses financial condition and operations, focusing on COVID-19 impacts, PPP, loan deferrals, and acquisitions, noting decreased net income due to higher loan loss provisions - Net income for the nine months ended September 30, 2020, was **$9.3 million**, down from **$13.5 million** in the prior-year period, mainly due to an increased provision for loan losses in response to the COVID-19 pandemic[246](index=246&type=chunk) - The company participated in the **Paycheck Protection Program (PPP)**, originating **$110.3 million** in PPP loans as of September 30, 2020, which are included in the commercial and industrial loan portfolio[228](index=228&type=chunk)[248](index=248&type=chunk) - The company terminated its pending acquisition of **Cheaha Financial Group, Inc.** on **June 30, 2020**, citing unpredictable economic conditions resulting from the COVID-19 pandemic[240](index=240&type=chunk)[241](index=241&type=chunk) - The allowance for loan losses increased significantly to **$19.0 million** at September 30, 2020, from **$10.7 million** at year-end 2019, primarily due to the change in economic conditions from the COVID-19 pandemic[307](index=307&type=chunk) [Financial Condition](index=51&type=section&id=Financial%20Condition) Total loans grew 8.1% to $1.83 billion, including PPP loans, while deposits increased 7.4% to $1.8 billion, and FHLB borrowings rose Loan Portfolio Composition (in thousands) | Loan Category | Sep 30, 2020 | Dec 31, 2019 | | :--- | :--- | :--- | | Total mortgage loans on real estate | $1,414,092 | $1,338,743 | | Commercial and industrial | $392,955 | $323,786 | | Consumer | $22,633 | $29,446 | | **Total loans** | **$1,829,680** | **$1,691,975** | - The loan portfolio includes exposure to industries significantly affected by the pandemic, such as oil and gas, food services, hospitality, and entertainment, which collectively represented **6.6%** of the total loan portfolio (**5.6%** excluding PPP loans) at September 30, 2020[255](index=255&type=chunk)[256](index=256&type=chunk) - As of September 30, 2020, loans participating in the 90-day deferral program totaled **$56.5 million**, or **3.1%** of the total loan portfolio, a balance that had decreased to **$17.9 million** by November 2, 2020[256](index=256&type=chunk) [Results of Operations](index=57&type=section&id=Results%20of%20Operations) Net interest income rose 13.6% to $54.4 million, but net interest margin declined; noninterest income and expenses increased, and loan loss provision surged Performance Summary (Nine Months Ended Sep 30) | Metric | 2020 | 2019 | | :--- | :--- | :--- | | Net Income | $9.3 million | $13.5 million | | Diluted EPS | $0.85 | $1.34 | | Return on Average Assets | 0.55% | 0.93% | | Return on Average Equity | 5.20% | 8.99% | | Net Interest Margin | 3.46% | 3.53% | - The cost of deposits decreased **30 basis points** to **1.21%** for the nine months ended September 30, 2020, compared to the prior year, as management strategically repriced or ran off higher-yielding time deposits[288](index=288&type=chunk) [Risk Management](index=63&type=section&id=Risk%20Management) The company manages credit, interest rate, and liquidity risks; allowance for loan losses increased to $19.0 million, and nonperforming loans rose to $12.4 million Allowance for Loan Losses Activity (in thousands) | | Nine Months Ended Sep 30, 2020 | Nine Months Ended Sep 30, 2019 | | :--- | :--- | :--- | | Beginning Balance | $10,700 | $9,454 | | Provision for loan losses | $8,760 | $1,172 | | Net Charge-offs | $(416) | $(287) | | **Ending Balance** | **$19,044** | **$10,339** | - The ratio of allowance for loan losses to total loans increased to **1.04%** at September 30, 2020, from **0.65%** a year prior, reflecting increased reserves due to the COVID-19 pandemic[316](index=316&type=chunk) - Nonperforming loans increased to **$12.4 million** at September 30, 2020, compared to **$6.3 million** at December 31, 2019[324](index=324&type=chunk) [Liquidity and Capital Resources](index=70&type=section&id=Liquidity%20and%20Capital%20Resources) Core deposits are the primary liquidity source, supplemented by investments and FHLB credit; the company maintained strong regulatory capital ratios and repurchased $10.8 million in stock Regulatory Capital Ratios (Investar Bank) | Ratio | Sep 30, 2020 | Minimum to be Well Capitalized | | :--- | :--- | :--- | | Tier 1 leverage capital | 10.23% | 5.00% | | Common equity tier 1 capital | 12.46% | 6.50% | | Tier 1 capital | 12.46% | 8.00% | | Total capital | 13.50% | 10.00% | - During the nine months ended September 30, 2020, the Company paid **$10.8 million** to repurchase **640,605 shares** of its common stock under its authorized share repurchase program[348](index=348&type=chunk) [Quantitative and Qualitative Disclosures about Market Risk](index=74&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) No material changes in market risk since December 31, 2019, with interest rate risk remaining the primary concern - There have been no material changes in the Company's market risk since December 31, 2019, other than those discussed within the MD&A section of this report[362](index=362&type=chunk) [Controls and Procedures](index=74&type=section&id=Item%204.%20Controls%20and%20Procedures) Disclosure controls and procedures were effective, with no material changes to internal controls, despite the shift to remote work - Management concluded that disclosure controls and procedures were **effective** as of September 30, 2020[363](index=363&type=chunk) - **No material changes** were made to the company's internal control over financial reporting during the quarter, and the shift to remote work due to COVID-19 did **not have a significant impact** on internal controls[364](index=364&type=chunk) Part II. Other Information [Risk Factors](index=75&type=section&id=Item%201A.%20Risk%20Factors) Updated risk factors focus on the uncertain and adverse impacts of the COVID-19 pandemic, including potential loan defaults and operational challenges - The primary updated risk factor relates to the **COVID-19 pandemic**, which has created significant economic uncertainty and adversely impacted the company's business, financial results, and the financial condition of its customers[367](index=367&type=chunk) - Potential future financial losses from the pandemic could stem from higher-than-anticipated loan defaults, reduced demand for loans and services, further increases in the allowance for loan losses, and lower market interest rates[369](index=369&type=chunk)[370](index=370&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=77&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company repurchased 211,469 shares at an average price of $13.92 during Q3 2020, with 285,729 shares remaining authorized Issuer Purchases of Equity Securities (Q3 2020) | Period | Total Shares Purchased | Average Price Paid | | :--- | :--- | :--- | | July 2020 | 213 | $15.21 | | August 2020 | 145,128 | $14.08 | | September 2020 | 66,128 | $13.58 | | **Total** | **211,469** | **$13.92** | - As of September 30, 2020, the company had **285,729 shares** remaining for repurchase under its authorized stock repurchase plan[377](index=377&type=chunk) [Exhibits](index=78&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with Form 10-Q, including agreements, governance documents, officer certifications, and XBRL data